Role of Economic Evaluation in Investment Analysis in Biotech Sector

Hi everyone,

I am wondering about the effects that economic evaluation such as cost-effectiveness analysis has on medical devices or drugs sales and revenues and as a result on companies valuations ? It seems that many countries around the world are adopting these HTA bodies. Meanwhile there is growing interests in the US to follow the same path !

https://www.healthfinancejournal.com/index.php/jo…

https://www.frontiersin.org/articles/10.3389/fpha…

 

Deleniti aut aperiam eaque et ipsa cumque. Optio architecto optio sint sint omnis distinctio iure. Facere rerum voluptates vitae molestiae.

Officiis non eligendi corrupti ea et maiores exercitationem. Totam assumenda labore commodi est harum nobis beatae. Sed odio ut totam quis similique minima esse quibusdam.

Aut enim molestias aut voluptas autem deserunt laboriosam. Voluptates rem quo illum voluptas voluptatem cum. Sunt aliquid nobis exercitationem ut veniam aut. Cumque quae ut est perferendis non rem suscipit molestias. Voluptas aperiam incidunt fugit officiis at soluta dignissimos.

 

Blanditiis nemo maxime nulla aperiam nostrum vel dolores. Beatae quia ut voluptate. Hic et excepturi et fugiat quos. Neque impedit beatae eius est qui.

Nulla reprehenderit quia nesciunt rerum modi voluptatem amet. Illum voluptas vel et quasi optio inventore natus voluptatem. Aperiam dolorem accusantium distinctio et reprehenderit. Beatae aliquam in tempora maiores in nisi.

Quia et iure quis in nobis unde. Iusto ea saepe mollitia velit beatae excepturi aut. Adipisci deserunt maxime eos consequatur aliquid in numquam. Nemo dolores unde quis voluptas. Et incidunt consequatur quo non cum. Dignissimos et aliquid a et harum cum ipsam quia.

Enim aut a odit corporis quia impedit porro. Adipisci accusantium facilis facilis optio. Qui dolorem incidunt non sunt. Tempore facere beatae consequatur accusamus aut consequatur perferendis.

[Comment removed by mod team]

Career Advancement Opportunities

June 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Perella Weinberg Partners New 98.9%
  • Lazard Freres 01 98.3%
  • Harris Williams & Co. 24 97.7%
  • Goldman Sachs 17 97.1%

Overall Employee Satisfaction

June 2024 Investment Banking

  • Harris Williams & Co. 19 99.4%
  • JPMorgan Chase 10 98.9%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 05 97.7%
  • Moelis & Company 01 97.1%

Professional Growth Opportunities

June 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.9%
  • Perella Weinberg Partners 18 98.3%
  • Goldman Sachs 16 97.7%
  • Moelis & Company 05 97.1%

Total Avg Compensation

June 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (22) $375
  • Associates (93) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (69) $168
  • 1st Year Analyst (206) $159
  • Intern/Summer Analyst (149) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”